KIP Share Price Performance
Recent KIP News & Updates
No updates
Kolinpharma S.p.A. Key Details
Last Reported Earnings
Dec 31, 2022
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0.21
- Gross Margin
- 52.71%
- Net Profit Margin
- 2.19%
- Debt/Equity Ratio
- 105.3%
Kolinpharma S.p.A. Competitors
About KIP
- Founded
- 2013
- Employees
- 107
- CEO
- WebsiteView website
Kolinpharma S.p.A. operates as a nutraceuticals company in Italy. The company engages in the development and marketing of food supplements. It provides multivitamins, energizers and dietetics, and drugs. The company offers products intended for the prevention and co-adjuvant treatment of traditional pharmacological therapies in medical areas, such as urology and gynecology, orthopedics, physiatry, and traumatology. As of December 31, 2020, it had a network of 51 medical scientific informers. The company serves pharmaceutical wholesalers. Kolinpharma S.p.A. was founded in 2013 and is headquartered in Lainate, Italy.
Italian Market Performance
- 7 Days: -2.1%
- 3 Months: 3.3%
- 1 Year: 22.3%
- Year to Date: 14.4%
Over the last 7 days, the market has dropped 2.1%, driven by a decline of 9.9% in the Consumer Discretionary sector. As for the longer term, the market has actually risen by 22% in the last year. As for the next few years, earnings are expected to grow by 8.3% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading